Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Consider benefits and risks of new alopecia treatments for safety.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

COVID-19 may harm male fertility and damage the reproductive system.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

High levels of the seizure medication sodium valproate can cause hair loss.